Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
03/2012
03/07/2012CN102367243A Stable potassium sodium dehydroandroan drographolide succinate compound and pharmaceutical composition thereof
03/07/2012CN102366621A Plant estrogenic effect of acanthopanax biochemical traditional Chinese medicine compound extract and its application
03/07/2012CN102366554A Traditional Chinese medicinal preparation for treating hypercortisolism
03/07/2012CN102366550A Traditional Chinese medicine for treating diabetes insipidus
03/07/2012CN102366535A Chinese patent medicine for treating diabetes insipidus
03/07/2012CN102366516A Traditional Chinese medicine composition for treating hypercortisolism
03/07/2012CN102366510A Traditional Chinese medicine for treating hypercortisolism
03/07/2012CN102366494A Chinese patent medicine for treating hypercortisolism
03/07/2012CN102366412A Preparation method of tolvaptan tablet
03/07/2012CN102366402A Scopolamine hydrobromide injection and production technology
03/07/2012CN102166311B Preparation method of Chinese medicine for treating spleen-deficiency sthenic liver-energy hyperthyroidism
03/06/2012US8129339 Microencapsulation and sustained release of biologically active polypeptides
03/06/2012US8129132 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders
03/06/2012US8128964 Transdermal pharmaceutical delivery composition
03/06/2012CA2452881C Novel bicyclic and tricyclic cannabinoids
03/01/2012WO2012025811A1 Indolylpyrimidines as modulators of gpr119
03/01/2012WO2012025638A1 Selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors
03/01/2012WO2011069038A3 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
03/01/2012US20120053235 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053210 Compounds that modulate intracellular calcium
03/01/2012US20120053156 Compositions and methods for loop diuretics with consistent bioavailability
03/01/2012US20120053122 Method for the prophylaxis or treatment of flushing
03/01/2012US20120052077 Therapeutic modulation of vaginal epithelium boundary lubrication
03/01/2012US20120052005 Combination therapy to improve drug efficiency
02/2012
02/29/2012EP2423194A1 NOVEL THYROID HORMONE beta RECEPTOR AGONIST
02/29/2012EP1740213B1 Liquid growth hormone formulation
02/29/2012EP1669350B1 Piperidine derivatives
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN101267830B Growth hormone secretagogues
02/29/2012CN101060838B Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
02/28/2012US8124647 Non-steroidal androgens compounds
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124356 Methods of purifying zsig33
02/23/2012WO2012023254A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid
02/23/2012WO2011109367A4 Methods and compositions for treating or preventing symptoms of hormonal variations
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs
02/23/2012US20120046330 Pharmaceutical compositions of (r)-1-(2,2-difluorobenzo[d] [1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046252 Calcium Formate for Use as a Dietary Supplement
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/22/2012EP2419097A1 Pharmaceutical compositions
02/22/2012EP2093228B1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
02/22/2012EP1534289B2 Adenosine a2a receptor antagonists for treating restless legs syndrome or nocturnal myoclonus
02/22/2012CN102358750A Helix 12 directed pharmaceutical products
02/22/2012CN102357247A Therapeutic methods and delivery systems utilizing sex steroid precursors
02/22/2012CN102357229A Traditional Chinese medicine for treating thyroma
02/22/2012CN102357098A Pharmaceutical composition, uses and preparing method thereof
02/22/2012CN102085269B 一种用于多囊卵巢综合症的中药组合物及应用 A Chinese medicinal composition and application of polycystic ovary syndrome
02/21/2012US8119774 Cell marker for hepatic and pancreatic stem cells and progenitor cells
02/21/2012US8119619 Pregnane steroids and their use in the treatment of CNS disorders
02/21/2012CA2528784C Hexahydropyridoisoquinolines as dpp-iv inhibitors
02/21/2012CA2488372C Pyridazine derivatives which are phosphodiasterase iv inhibitors
02/21/2012CA2451981C 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
02/21/2012CA2418962C Anti-dual integrin antibodies, compositions, methods and uses
02/21/2012CA2400141C Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
02/21/2012CA2394716C Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
02/21/2012CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
02/16/2012WO2012020217A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2012020215A1 Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
02/16/2012WO2011163183A3 Methods for delaying progression of diabetes using salacia oblonga extract
02/16/2012WO2011160630A3 Glucagon analogues
02/16/2012US20120041524 Compositions for Providing Vitamin D Year Round and Uses Thereof
02/16/2012US20120041012 Substituted spirocyclic amines useful as antidiabetic compounds
02/16/2012US20120040982 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
02/16/2012US20120040964 N-substituted piperidines and their use as pharmaceuticals
02/16/2012US20120040886 Analogues of Neuropeptide Y Having Proline Substitution At Position 34
02/16/2012US20120040885 Analogues of Neuropeptide Y Having At Least One Synthetic Amino Acid Substitution
02/16/2012US20120040012 Therapeutic stem cell nutrient composition and uses thereof
02/16/2012US20120038073 Spray drying methods and related compositions
02/16/2012DE102009007771B4 Bukkales Applikationssystem, 17α-Estradiol enthaltend Buccal delivery system, 17α-estradiol containing
02/15/2012EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group
02/15/2012EP2416783A1 Improved glucocorticoid therapy
02/15/2012EP1755572B1 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators
02/15/2012CN1911206B 水性毛发洗净剂 The aqueous hair cleansing
02/15/2012CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
02/15/2012CN102351853A Azilsartan medoxomil compound, preparation method and medicinal composition thereof
02/15/2012CN102351732A Nuclear receptor binding agents
02/15/2012CN101948464B 3,4,6-三芳基-[1,3]-噁嗪-2-酮类化合物、其制备方法和用途 3,4,6-triaryl - [1,3] - oxazin-2-ones compounds, their preparation and use
02/15/2012CN101440343B 苦瓜保健酒及其配制方法 Bitter health wine and its preparation method
02/15/2012CN101421273B 螺咪唑化合物 Lo imidazole compounds
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
02/14/2012US8114442 Transdermal pharmaceutical delivery compositions
02/09/2012WO2012017451A1 A bio-stabilized resveratrol formulation
02/09/2012WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/09/2012WO2011127232A3 Substituted androst-4-ene diones
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035179 Modulators of atp-binding cassette transporters
02/09/2012US20120035158 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
02/09/2012US20120035155 Indole-2-carboxamide deivative
02/09/2012US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye
02/09/2012US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
02/09/2012CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
02/08/2012EP1509518B1 Calcium receptor modulating agents
02/08/2012CN102342935A Berberine-phenylacetic acid derivative, pharmaceutically acceptable salt thereof and application thereof
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 290